Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Patient selection for cytoreductive nephrectomy

Anil Kapoor, MD, FRCSC, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada, outlines the importance of careful patient selection for cytoreductive nephrectomy, referencing the CARMENA trial (NCT00930033), which tests the benefit of nephrectomy compared to sunitinib. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.